InVitae (NVTA) Misses Q3 EPS by 5c

InVitae (NYSE: NVTA) reported Q3 EPS of ($0.77), $0.05 worse than the analyst estimate of ($0.72). Revenue for the quarter came in at $6.28 million versus the consensus estimate of $7.5 million.

For earnings history and earnings-related data on InVitae (NVTA) click here.

You May Also Be Interested In

• Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
• Tenon Medical (TNON) Misses Q2 EPS by 395c
• Stardust Power (SDST) Tops Q2 EPS by 1c